PharmaVoice

JULY 25, 2022

Inozyme Pharma has joined a genomic sequencing program developing a novel rapid test for 388 genetic diseases.

264

264

Pharmacy Times

JULY 25, 2022

Participants took about 50 times higher than the recommended daily allowance every day for a month, investigators say.

139

139

PharmaVoice

JULY 25, 2022

A combined venture with Roivant — called Priovant Therapeutics — is looking to be a forerunner in the burgeoning autoimmune disease market.

264

264

Outsourcing Pharma

JULY 25, 2022

During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

125

125

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

JULY 25, 2022

The latest trial failures in Alzheimer's have shown cracks in the foundation of ingrained theories like amyloid plaque clearance. What will it take to move forward?

246

246

PharmExec

JULY 25, 2022

First-party insights bridge marketing and sales to deliver better HCP experiences.

124

124

Pharmacy Times

JULY 25, 2022

People living with psoriatic arthritis deserve to be informed about ways to approach disease management holistically and with a personalized approach.

123

123

Pharmaceutical Technology

JULY 25, 2022

With decreasing margins on the horizon, pharma manufacturers have long shown an interest in specialty generics, which is only expected to rise in the future. Despite this, specialty generics are expected to be the domain of a handful of companies with the necessary manufacturing capabilities and legal backing needed for entering the market. Specialty generics is a term used to refer to generic versions of drugs that are often expensive, complex, or “high touch”—requiring significant involvement

FDA 119

FDA Medical Schools Dosage 119

Pharmacy Times

JULY 25, 2022

Combining tramadol and celecoxib into a co-crystal of celecoxib-tramadol provides peripherally and centrally mediated analgesia.

123

123

European Pharmaceutical Review

JULY 25, 2022

The European Commission (EC) has issued a draft proposal for a new EU Regulation on blood, tissues and cells (BTC) to help increase the safety and quality of substances of human origin (SoHO). The Regulation will cover all SoHO (eg, blood, tissues, cells, breast milk and microbiota) except solid organs. A major aim of the proposal is to enhance the protection of recipients of SoHO therapies, as well as donors of SoHO and offspring from medically assisted reproduction.

116

116

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 25, 2022

Along with expanding responsibilities, pharmacies must have the infrastructure and pharmacy staff must have sufficient support.

123

123

Pharmaceutical Technology

JULY 25, 2022

The COVID-19 pandemic triggered significant changes to the way healthcare operates. Digitalization is now in full swing as medical care integrates with ICT to take the patient experience to the next level. According to Tom Lenaerts, Head of Global Process Engineering at Datwyler, this transformation will reshape the entire healthcare ecosystem. “There are already opportunities for patients to track their health through smart medical devices sending reports directly to their healthcare provider.

Health and Personal Care Stores 114

Health and Personal Care Stores Packaging Patient Care 114

Pharmacy Times

JULY 25, 2022

From a patient perspective, the lack of awareness of biosimilars is the biggest barrier to adoption.

123

123

European Pharmaceutical Review

JULY 25, 2022

While the global trade of fake pharmaceuticals has long been a threat, the COVID-19 pandemic sent the fraudulent market into overdrive. Criminals were able to capitalise on supply chain disruptions, industry regulations being in transition and the urgent global demand for medical products; consequently they thrived. A week before COVID-19 was even declared a pandemic by the World Health Organization (WHO), 1 Interpol’s Operation Pangea XIII seized counterfeit virus interventions 2 worth $14 mill

Packaging 104

Packaging 104

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 25, 2022

Once the revisions to become approved, there will be a minimum grace period of 6 months for pharmacies to comply.

Documentation 122

Documentation 122

pharmaphorum

JULY 25, 2022

Roche has been trumpeting the rapid uptake of its new eye disease drug Vabysmo as it takes on Regeneron and Bayer’s mighty Eylea in the US – and could soon start making inroads against its rival in Europe. Vabysmo (faricimab) has been recommended by the EMA’s human medicines committee as a treatment for neovascular or wet age-related macular degeneration (AMD) and diabetic macular oedema (DME), so could be fully approved and ready to roll out in the next few months, subject to pricin

FDA 99

FDA Immunization 99

Pharmacy Times

JULY 25, 2022

Kevin Straughn, PharmD, clinical pharmacist at Duke Regional Hospital, said once the 2 compounding chapters, and become enforceable, there will be a 6-month grace period before USP becomes enforceable.

Compounding 94

Compounding Hospitals 94

Pharmaceutical Technology

JULY 25, 2022

The proportion of pharmaceutical companies hiring for machine learning related positions rose in June 2022 compared with the equivalent month last year, with 26.4% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 24.1% of companies who were hiring for machine learning related jobs a year ago and an increase compared to the figure of 26.3% in May 2022.

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies 93

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 25, 2022

This is important to establish when deciding on a pharmacy focus or making a career change.

65

65

pharmaphorum

JULY 25, 2022

Shares in VistaGen Therapeutics have plummeted after the company reported that its lead pherine nasal spray candidate failed the first of two phase 3 trials in social anxiety disorder (SAD), placing the future of the programme in doubt. The drug – codenamed PH94B – was unable to alleviate SAD symptoms in adults asked to complete a public speaking challenge in the PALISADE-1 compared to placebo.

FDA 59

FDA 59

Pharmacy Times

JULY 25, 2022

This month's featured products include viloxazine extended-releast capsules, lumateperone, and more.

65

65

The Social Pharmacist

JULY 25, 2022

The recent iOS 14 updates resonated with the immense significance of digital privacy among its users from the past years. Its implementation gave consumers more control over the data they unknowingly share with advertisers and publishers. . In response to the upcoming changes, Facebook has indicated that they expect the amount of data available for ad targeting and measurement to decrease as users “opt-out” of tracking.

52

52

Pharmacy Times

JULY 25, 2022

Health Mart University also offers "basic technician training programs," to allow pharmacies to bring those new technicians on board, help them meet the PTCB examination standards, and really get that new technician ready to go.

PTCB 65

PTCB 65

OctariusRx

JULY 25, 2022

This week we are once again providing an update on the most recent drug shortages. Drug shortages currently remain at over 100 different medications, with the Food and Drug Administration (FDA) noting 118 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.

Long-Term Care Facilities 52

Long-Term Care Facilities FDA 52

Pharmacy Times

JULY 25, 2022

Alocane provides fast pain relief and helps the healing process from minor burns.

65

65

Pharmaceutical Technology

JULY 25, 2022

Concept: Austin-based robotics startup Apptronik has unveiled a humanoid robot named Astro. It is a general-purpose robot that can work alongside humans. Nature of Disruption: Astro is a human-centered robotic system that includes vision-based grasping. It leverages ML technology to find, grab and pick up objects. The robot has modern actuation packed into a small form factor.

52

52

Pharmacy Times

JULY 25, 2022

Piperacillin and tazobactam (Zosyn) is indicated for treatment of intra-abdominal infections, skin and skin structure infections, female pelvic infections, community-acquired pneumonia, and nosocomial pneumonia.

65

65

Outsourcing Pharma

JULY 25, 2022

A leader from the CRO discusses how capturing the perspective of trial participants can help ensure development of treatments that meet the patientsâ needs.

52

52

Pharmacy Times

JULY 25, 2022

Delayed diagnosis in younger individuals and presentation of advanced disease highlights need for awareness.

65

65

Pharmaceutical Commerce

JULY 25, 2022

Cold chain logistics deal expands business’ international reach.

52

52

pharmaphorum

JULY 25, 2022

Zymergen’s brand new plan to shift from a synthetic biology specialist to a drug discovery player has come to an early end, with the sale of the company to rival Ginkgo Bioworks. The all-stock transaction values Zymergen at an approximately $300 million, a fraction of the $1 billion it raised in venture funding with another $530 million from its initial public offering in April 2021.

52

52

Pharmaceutical Commerce

JULY 25, 2022

New 154,000 square-foot center will house several of the pharma company’s business units.

52

52

Pharmaceutical Technology

JULY 25, 2022

AstraZeneca and Daiichi Sankyo have received Priority Review for their supplemental Biologics License Application (sBLA) from the US Food and Drug Administration (FDA) of antibody-drug conjugate (ADC), Enhertu (trastuzumab deruxtecan), to treat unresectable or metastatic HER2-low breast cancer in adults. The treatment is intended for HER2-low immunohistochemistry [IHC] 1+ or IHC 2+/in-situ hybridisation [ISH]-negative breast cancer patients who have previously received treatment in the metastati

FDA 52

FDA Chemotherapy Labelling 52